国外对超说明书用药的态度和医保覆盖情况及其启示  

Attitude and medical insurance coverage for off-label use in various countries

作　　者：刘容吉[1] 牛子冉 左玮[1] 胡扬[1] 张波[1] Liu Rongji;Niu Ziran;Zuo Wei;Hu Yang;Zhang Bo(Departmen of Pharmacy,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China)

机构地区：[1]中国医学科学院北京协和医院药剂科,北京100730

出　　处：《中华医院管理杂志》2021年第10期838-842,共5页Chinese Journal of Hospital Administration

摘　　要：超说明书用药是世界各国临床实践中普遍遇到的一个问题,各国针对超说明书用药的管理现状、态度及医保报销情况存在较大差异。作者通过分析各国超说明书用药的管理情况和医保报销制度,建议我国应加快建设超说明书用药相关制度及建立相关管理体系,强化超说明书用药监管,以保障患者获得最佳治疗的权利。Off-label drug use is a global problem in clinical practice.The management status,attitude and medical insurance coverage of off-label drug use are different in various countries.By analyzing the management and reimbursement policy of off-label drug use in other countries,the authors suggested that China should speed up the institutional arrangements of off-label drug use and establish relevant management systems,and strengthen the supervision of off-label drug use,so as to guarantee the rights of patients to the best treatment.

关 键 词：超说明书用药 政策法规 医保报销 监管 患者权利 

分 类 号：R95[医药卫生—药学]